U.S. nod for Chennai pharma major's antibiotic

Tuesday, 25 February 2003, 08:00 Hrs
Printer Print Email Email
CHENNAI: An antibiotic manufactured by a Chennai-based company has been okayed for entry into the U.S.

Orchid Chemicals & Pharmaceuticals Ltd. has received a formal approval from the U.S. Federal Drug Authority (USFDA) to make Cephalexine.

The product has also been granted the certificate of suitability (CoS) by the European Directorate for Quality of Medicines (EDQM). The company has been granted CoS for Ceftriaxone sodium.

"We are extremely happy about these developments. Both these milestones will definitely enable a stronger entry into the U.S. and European markets," K. Raghavendra Rao, managing director of Orchid Chemicals, said here.

Orchid is India's largest cephalosporin-based drug manufacturer.




Source: IANS
SPOTLIGHT
Google's Gboard gets offline
Google is adding an Artificially Intelligent (AI) offline dictation feature on its Gboard keyb..
Facebook denies cyber attack
Facebook ruled out a cyber attack on its products Whatsapp, Instagram and Messenger, which suf..
Wipro opens third industrial
IT major Wipro Ltd on Thursday opened its centre of excellence for Industrial Internet of Things (..
IBM announces programme
n a bid to recognise the contribution of developers in the open source community, Information ..